Share on LinkedInShare on LinkedIn

ARTICLE · 22 AUGUST 2022

What Is The Aziyo FiberCel Case All About?

FiberCel is a fiber-based bone repair product manufactured by Aziyo and distributed in the U.S. by Medtronic.

United StatesLitigation, Mediation & Arbitration

On June 16, 2021, Morris James LLP filed a lawsuit against Aziyo Biologics, Inc. (Aziyo) and Medtronic entities (Medtronic) on behalf of Delawarean, Richard Williams after he became infected with tuberculosis after spine surgery. This is the first lawsuit filed in relation to the contamination of FiberCel Viable Bone Matrix (FiberCel) with tuberculosis (TB.)

FiberCel is a fiber-based bone repair product manufactured by Aziyo and distributed in the U.S. by Medtronic. It is made from human tissue and engineered to maintain characteristics of natural tissue. FiberCel is used in orthopedic or reconstructive bone grafting procedures in combination with autologous or allograft bone, or alone as a bone graft. (Autologous bone is the patient's own bone whereas allograft bone comes from a donor.)

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from